Solid State Characterization and Dissolution Enhancement of Nevirapine Cocrystals

Purpose: Novel cocrystals of nevirapine (NP) were designed and prepared with salicylamide and 3-hydroxy benzoic acid (3-HBA). Methods: The cocrystals were prepared by solvent drop grinding method by adding few drops of acetone to enhance the solubility and dissolution. The drug and cocrystals were characterized by differential scanning calorimetry (DSC) and powder x-ray diffraction (PXRD). The solubility of NP, its wet ground form, and cocrystals were investigated at different pH. Moreover, the effect of surfactant on solubility of cocrystals was also studied. Finally, intrinsic dissolution rate (IDR) and stability of cocrystals was examined. Results: The characterization of cocrystals by DSC and PXRD revealed formation of new solid forms due to changes in thermogram and PXRD pattern. The cocrystal of NP with 3-HBA showed 4.5 folds greater solubility in pH 1.2 buffer and 5.5 folds in 1% Tween 80 as compared to original drug. IDR of cocrystals was higher than the pure drug in 0.1 N hydrochloric acid (HCl). Moreover, cocrystals were found physically stable after 3 months as evident from unchanged IDR. Conclusion: Hence, the present research indicates the new stable solid forms of NP with improved dissolution rate than pure drug.

[1]  Hailu Zhang,et al.  Crystal Structures, Dissolution and Pharmacokinetic Study on a Novel Phosphodiesterase-4 Inhibitor Chlorbipram Cocrystals. , 2019, International journal of pharmaceutics.

[2]  P. Panzade,et al.  Design and Preparation of Zaltoprofen-Nicotinamide Pharmaceutical Cocrystals via Liquid Assisted Grinding Method , 2019, Indian Journal of Pharmaceutical Education and Research.

[3]  Venu R. Vangala,et al.  Pharmaceutical Cocrystals: Molecules, Crystals, Formulations, Medicines , 2019, Crystal Growth & Design.

[4]  J. Vela,et al.  Co-crystals as a new approach to multimodal analgesia and the treatment of pain , 2019, Journal of pain research.

[5]  P. Rathi,et al.  Nevirapine Pharmaceutical Cocrystal: Design, Development and Formulation , 2019, Drug Delivery Letters.

[6]  M. Ganesh,et al.  Chitosan-telmisartan polymeric cocrystals for improving oral absorption: In vitro and in vivo evaluation. , 2019, International journal of biological macromolecules.

[7]  G. E. El Maghraby,et al.  Co-crystallization for enhanced dissolution rate of bicalutamide: preparation and evaluation of rapidly disintegrating tablets , 2019, Drug development and industrial pharmacy.

[8]  S. Mandal,et al.  Cocrystal of 5-Fluorouracil: Characterization and Evaluation of Biopharmaceutical Parameters , 2019, AAPS PharmSciTech.

[9]  G. Walker,et al.  Pharmaceutical cocrystals: from serendipity to design to application. , 2019, Drug discovery today.

[10]  C. D. Kaur,et al.  Pharmaceutical Cocrystal: A Novel Approach to Tailor the Biopharmaceutical Properties of a Poorly Water Soluble Drug. , 2019, Recent patents on drug delivery & formulation.

[11]  M. Prakash,et al.  Lower melting pharmaceutical cocrystals of metaxalone with carboxamide functionalities , 2019, Journal of Molecular Structure.

[12]  G. Walker,et al.  Pharmaceutical Cocrystal Drug Products: An Outlook on Product Development. , 2018, Trends in pharmacological sciences.

[13]  Feng Wang,et al.  Solid-state characterization and solubility enhancement of apremilast drug-drug cocrystals , 2018 .

[14]  N. Bukhari,et al.  Simultaneously Improving Mechanical, Formulation, and In Vivo Performance of Naproxen by Co-Crystallization , 2018, AAPS PharmSciTech.

[15]  P. Panzade,et al.  Pharmaceutical Cocrystal: An Antique and Multifaceted Approach. , 2017, Current drug delivery.

[16]  Sunil Kumar Nechipadappu,et al.  Pharmaceutical Co-Crystal of Flufenamic Acid: Synthesis and Characterization of Two Novel Drug-Drug Co-Crystal. , 2017, Journal of pharmaceutical sciences.

[17]  V. Garg,et al.  Stable Co-crystals of Glipizide with Enhanced Dissolution Profiles: Preparation and Characterization , 2017, AAPS PharmSciTech.

[18]  Changquan Calvin Sun,et al.  The development of carbamazepine-succinic acid cocrystal tablet formulations with improved in vitro and in vivo performance , 2016, Drug development and industrial pharmacy.

[19]  S. Bourne,et al.  Co-crystals of the antiretroviral nevirapine: crystal structures, thermal analysis and dissolution behaviour , 2012 .

[20]  H. Samsodien,et al.  FTIR, Dissolution and Anti-viral Activity of Nevirapine Co-crystals , 2017 .

[21]  Changquan Calvin Sun,et al.  Improving Dissolution Rate of Carbamazepine-Glutaric Acid Cocrystal Through Solubilization by Excess Coformer , 2017, Pharmaceutical Research.